I started to lose my hair and go gray in my late 20s.
Now, at 47, I’ve got a full head of hair and ~70% of my gray is gone.
Here how I did it.. 🧵
Contrary to popular belief, you can maintain your hair well into your 40s and beyond.
In 12 months, I went from a Norwood 3 to a Norwood 2. Norwood is a hair loss scale, as indicated in the image.
Here’s how I achieved these results:
1. Start early:
Don’t wait for visible loss.
Many lose up to 50% of their hair before they even realize it.
The best time to work on your hair is before you start losing it.
2. Nutrition:
Make sure you're getting adequate:
+ Protein: including collagen peptides and sufficient methionine, cyteine, and lysine in addition to taurine, to support collagen, keratin, and elastin synthesis. Ref (3)
+ Omega-3 fatty acids: for antioxidant effects and improving scalp circulation. Ref (4)
+ Key vitamins & minerals: including iron, selenium, and biotin. Ref (3)
The Blueprint stack has all of these. ↓
3. Customized topicals:
I use a personalized Rx formula based on my genetics to prevent and reverse hair loss. Roots byGA (5)
Here are the ingredients in my formulation: Minoxidil (7%), Cetirizine HCl (1%), Latanoprost (0.004%), Dutasteride (0.25%), Melatonin (0.1%), Caffeine (0.2%), Tretinoin (0.0125%), Vitamin D3 (1,000IU/ML), Vitamin E (10 IU/ML).
5% minoxidil is a solid budget alternative. Apply 1 mL to scalp at night or in the morning (or both), massage thoroughly.
Note that some people experience side effects with a topical such as itchy skin, headaches etc. so monitor for those.
4. Red light therapy:
Six minutes a day and you can be doing your morning routine as you wear it. A study on 44 males (age 18-49) showed that treatment with 655nm laser cap for 25 min every other day for a duration of 16 weeks resulted in a 39% increase in hair growth compared to placebo. Ref (6)
An affordable Blueprint red light cap coming soon.
5. Oral minoxidil:
I take 3.75 mg a day. I started with 2.5 mg and evaluated for side effects.
In a double-blind, placebo-controlled randomized clinical trial involving 90 men with androgenetic alopecia AGA, oral minoxidil (5 mg daily) was found to have similar efficacy to topical minoxidil (5% solution applied twice daily) after 24 weeks.Ref (7)
Oral minoxidil is generally considered safe at low doses, but it can have side effects such as hypertrichosis (excessive hair growth) and headaches.
When starting any new hair regimen:
+ Start slow
+ Introduce 1 product at a time
+ Monitor closely for side effects
+ Give each addition 3 months to show results
+ 5% minoxidil alone is sufficient for many
+ Consider personalization based on your genetic profile, health, diet type and nutritional condition to reverse any deficiencies (e.g. omega3, protein...) revealed by blood testing.
In December, I'll have a hair growth serum for you. I've been experimenting and refining the formulation for two years.
A final note that I’m in touch with several companies that are building novel hair regrowth therapies. They are promising and exciting.
They’re still years out but it’s cool to think that hair loss may no longer be a thing we have to think about. Just one reason why the future is going to be amazing. #dontdie
For my full protocols and guides visit Project Blueprint here:
My birthday is every 21 months. I have the best comprehensive biomarkers of anyone in the world. Step by step to longevity escape velocity. I'm bringing you with me.
What is speed of aging?
How to slow yours?
🧵
0/ What is the speed of aging?
Aging isn’t just about growing older as the time passes, it's about how fast you're aging.
The speed of aging refers to how quickly your biological systems accumulate damage and decline in function.
Two people born on the same day can have drastically different biological ages depending on lifestyle, genetics, and environment.
It’s not just about your years lived but how your body has aged during those years.
Think of your body as a car:
+ Chronological Age is how many years the car has been on the road.
+ Biological Age is how worn out the engine and parts are.
The speed of aging tells us how quickly you're wearing out those parts. Faster speed = quicker breakdown.
Keeping with the car analogy, the DNA methylation biological aging clocks are essentially cellular odometers.
1/ How do you slow your speed of aging?
Short answer: do what I do. I share everything for free and make Blueprint products so that it's easy for you to have the best nutrition, third party tested and at a low price. Also cool if you don't buy Blueprint. I share everything so you can go out and do it by yourself.
No one thinks of hyperbaric oxygen therapy (HBOT) as a glow-up, but it is, for whole-body skin rejuvenation.
It creates stronger, firmer, bouncier, and glowing skin.
The data is compelling.
Let's look at the evidence.
🧵
0⃣ What is HBOT? Hyperbaric Oxygen Therapy involves breathing pure or nearly pure oxygen (95-100%) at increased atmospheric pressure. It’s been used for decades for wound healing & recovery (1)(2). But its benefit seems to extend beyond skin healing towards skin longevity and rejuvenation.
1⃣ HBOT shows promise in skin rejuvenation
A promising 2021 prospective clinical trial explored how HBOT affects skin aging in healthy older adults (average age= 68±2.5) (3)
HBOT Protocol: 90 min, 100% oxygen at 2x atmospheric pressures
Examination & measurement: skin biopsies from the flap behind the ear (1-2 weeks after last HBOT session), isolated from sunlight and other factors, to eliminate “extrinsic” skin aging factors, and focus on “intrinsic” aging and rejuvenation.
Researchers found significant improvements in skin quality at the cellular and tissue levels. Here’s what they discovered.
I'm starting a new longevity protocol: microdosing Tirzepatide, a dual GLP-1/GIP receptor agonist.
Here is the existing evidence, my protocol, measurement plan, and what I expect to achieve by this intervention.
🧵
1/ Here’s what I’m doing and why:
What is a GLP-1RA?
A GLP-1-RA is a medication that mimics the hormone glucagon-like peptide-1, crucial for regulating blood sugar and appetite. They’re approved for managing type 2 diabetes and aiding in weight loss by reducing blood sugar levels and increasing the feeling of satiation by extending the time of digestion in the stomach.
The use of GLP-1a has surged, with a 700% increase from 2019 to 2023 among U.S. patients without diabetes but who are overweight or obese. (1)
These medications are approved for managing type 2 diabetes (e.g. Ozempic) and, in higher doses, to support weight loss in people with excessive weight (e.g. Wegovy).
Robust evidence indicates that GLP-1 agonists have a rejuvenating and anti aging effect in obese people. (2)
More recent evidence suggests a potential for GLP-1 agonists in preventing age related disease in non-obese people too, as was demonstrated that its effect in reducing Alzheimer disease risk outweighed all other diabetes medications with similar risk reduction in normal weight and obese participants (3).
There has been growing scientific data suggesting that these meds are also beneficial for longevity via several mechanisms that are independent from weight loss.
2/ Metabolic and Longevity Benefits
Metabolic Optimization: Less glucose spikes, lower insulin levels, and thus reduced advanced glycation end-products (AGEs) (4, 5).
Anti-Inflammatory Effects: Systemic inflammation reduction by decreasing pro-inflammatory cytokines like TNF-α and IL-6, and improving gut microbiota, thereby reducing systemic immune activation (6, 7).
Mitochondrial Health: Enhanced mitochondrial biogenesis and function, prevention of mitochondrial dysfunction, reduced reactive oxygen species (ROS), and improved cellular energy metabolism (8, 9).
Caloric Restriction Mimicry: Mimics metabolic effects of caloric restriction, including reduced mTOR signaling, enhanced autophagy, and improved metabolic flexibility (10).
Multi-organ rejuvenation a new pre-print demonstrated that GLP1-RA in mice had comparable effects to mTOR inhibition by rapamycin (a well established rejuvenation intervention in mice) in reversing biological aging across multiple organs as evaluated using epigenetic biological age clocks.(11)
Daily Mail misinterpreted scientific evidence and doctors piled on, spreading misinformation and making you sound dumb if repeated.
🧵
1/ It's best to not get your science from Daily Mail
They recently published this article where they managed to make a textbook example of how not to report scientific studies. All worst practices put into one article.
Doctors further shared the bad take, fueling their own confirmation bias, to win impressions.
Let's look at Daily Mail’s bad science reporting.
2/ Misrepresentation of a completely unrelated peer-reviewed article
Daily Mail and this doctor wanted to jump on the bandwagon of unconfirmed bias against seed oil.
However without credible evidence, they misrepresented a legitimate peer-reviewed story.
Unfortunately, such practices are too common in science journalism, only this time their take was pretty it audacious.
The article blaming oil intake for exacerbating colon cancer has nothing to do with nutrition, oil or dietary fats.
The paper investigated tumors using integrated single-cell gene expression analysis and lipidomics (analysis of fat molecules in the cell) to investigate the root causes of chronic inflammation that drives the cancers, and identify the genes responsible for it (2).
The team behind the study identified a “lipid switching” happening in colon cancer cells that makes them prone to chronic inflammation, this happened due to a shift in gene expression leading to a modest increase in Arachidonic Acid levels, and an imbalance of gene expression favoring the pro-inflammatory derivatives of arachidonic acid (Leukotrienes LTB4, LTC4) on the expense of inflammation-resolving Lipoxins (LXA4, LXB4), leading to inflammation becoming chronic and contributing to tumor progression.
Heading into MAHA, what is America's baseline health?
The worst healthspan-lifespan gap in the world, 29% higher than the global average.
Meaning, the average American spends 12.4 years in poor health, mostly due to chronic age-related disease.
🧵
1/ Humans live longer since the turn of the century, but health is yet to catch up.
A study published last week reported that while average lifespan has increased since the beginning of this century, people are also spending more years in poor health. widening the healthspan-lifespan gap.
The study assessed lifespan and healthspan trends from 183 WHO member countries by analyzing the evolution of life expectancy (lifespan) and health-adjusted life-expectancy (healthspan).
Between years 2000 and 2019, global life expectancy has increased by 6.5 years to reach 73.1 years, while global health-adjusted life expectancy only increased by 5.4 years to reach 63.5 years.
2/ On average people live longer, but spend the last decade of their lives in poor health, developed countries have it worse.
The average global gap between healthspan and lifespan widened from 8.5 years in 2000, to 9.6 years in 2019.
This means that on average each person spends almost the last decade of their life in bad health, due to chronic age related disease, injury, or both.
Interestingly, the trend is worse in the developed countries that saw the largest gains in lifespan, but also suffer from a wider lifespan-healthspan gap.
Air pollution is one of the greatest threats to public health.
🧵
1/ Particulate pollution is set to reduce global average life expectancy by 1.9 years.
Contrast that with:
+ smoking (1.7 yrs)
+ child and maternal malnutrition (1.4 yrs)
+ alcohol use (5 months)
+ ; transportation injuries from vehicle accidents and unsafe water, sanitation and handwashing (4.8 months)
+ HIV/AIDS (3.4 months)
2/ Air pollution is poorly funded globally
HIV/AIDS receive $654 million annually from philanthropic foundations worldwide. Outdoor air pollution receives less than a tenth of that amount (41.3 million USD ) despite its larger global health burden.
The entire continent of Africa receives $238,000 annually in philanthropic funds toward air pollution—far less than the average price of a single-family home in the United States.
$825,000 goes to Asia annually, outside of China and India. Europe, the United States, and Canada, meanwhile, receive $21 million annually, according to the Clean Air Fund.